Summary
- Current Price
- As of today, ZNTL price is $5.00, up +1.01% on
- Current Price All-Time High
- ZNTL price is currently -94.27% below its historical high of $87.19 set on
- Market Cap
- ZNTL current market cap is $356M, up +257.55% over the past 365 days
- Revenue
- ZNTL current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for ZNTL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Zentalis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ZNTL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zentalis.com |
| Employees | 166 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $5.00 | ||
| Price, 1D Change | +1.01% | |
| $356M | ||
| - | ||
| - | ||
| 1.96 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.91 | ||
| EPS, 1Y Change | +18.26% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.91 | ||
| EPS Estimate | -$1.67 | N/A |
| EPS Est. Change | +12.52% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $5.00 | ||
| Price Target | $6.00 | - |
| Price Tgt. Change | +20.00% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.40 | -$2.33 | +2.87% | |
| -$1.98 | -$1.91 | +3.89% | |
| -$1.67 | N/A | +12.52% | |
| -$1.53 | N/A | +19.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $40.62M | $67.43M | +66.00% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $19.28M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +262.32% | ||
| -80.97% | ||
| +257.55% | ||
| -80.82% | ||
| -100.00% | ||
| 0.00% | ||
| +18.26% | ||
| +57.43% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $5.00 | ||
| $3.00 | ||
| $4.31 | ||
| $3.41 | ||
| $4.42 | ||
| $0.14 | ||
| 1.96 | ||
| $0.37 | ||
| 58.84 | ||
| 50.23% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.91 | ||
| $0.00 | ||
| - | ||
| -$145.01M | ||
| - | ||
| -$137.06M | ||
| - | ||
| -$145.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 6.93 | ||
| 6.93 | ||
| - | ||
| - | ||
| -3.59 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.95 | ||
| -1.26 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $216.20M | ||
| $245.89M | ||
| $288.97M | ||
| $253.19M | ||
| $72.76M | ||
| $36.56M | ||
| $39.58M | ||
| $3.87M | ||
| $7.21M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $137.06M | ||
| $145.01M | ||
| $0.00 | ||
| $0.00 | ||
| $739.00K | ||
| $0.00 | ||
| $442.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$125.25M | ||
| $131.62M | ||
| -$4.28M | ||
| $0.00 | ||
| -$125.25M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Rodman & Renshaw | ||
| Mizuho | ||
| Guggenheim | → | |
| Guggenheim | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ZNTL
FAQ
- What is the ticker symbol for Zentalis Pharmaceuticals, Inc.?
- The ticker symbol for Zentalis Pharmaceuticals, Inc. is NASDAQ:ZNTL
- Does Zentalis Pharmaceuticals, Inc. pay dividends?
- No, Zentalis Pharmaceuticals, Inc. does not pay dividends
- What sector is Zentalis Pharmaceuticals, Inc. in?
- Zentalis Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Zentalis Pharmaceuticals, Inc. in?
- Zentalis Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Zentalis Pharmaceuticals, Inc. based in?
- Zentalis Pharmaceuticals, Inc. is headquartered in United States
- When did Zentalis Pharmaceuticals, Inc. go public?
- Zentalis Pharmaceuticals, Inc. initial public offering (IPO) was on April 3, 2020
- Is Zentalis Pharmaceuticals, Inc. in the S&P 500?
- No, Zentalis Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Zentalis Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Zentalis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Zentalis Pharmaceuticals, Inc. in the Dow Jones?
- No, Zentalis Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Zentalis Pharmaceuticals, Inc. last earnings report?
- Zentalis Pharmaceuticals, Inc.'s most recent earnings report was on May 12, 2026
- When does Zentalis Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Zentalis Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- ZNTL Official Website zentalis.com
- ZNTL Profile on Yahoo Finance finance.yahoo.com/quote/ZNTL
- ZNTL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zntl